Coagulation Profile BV are delighted to share that the results of the VitaK-CAC study have today been published in JAMA Cardiology (1). Working in close collaboration with the study investigators at Maastricht University Medical Center, Coagulation Profile BV are proud to have contributed our analytical expertise to a clinical study that will help advance the understanding of the mechanisms and management of cardiovascular disease. The randomised, placebo-controlled Vitamin

We are proud to share the results of a research study that highlights an innovative intrinsic pathway approach to thrombin generation testing for monitoring treatment with non-factor replacement therapies in severe haemophilia A, developed by Coagulation Profile B.V. in close collaboration with scientists and clinicians at Maastricht University. The study, entitled “Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alpha and emicizumab i

We are proud to share that a research study conducted by Coagulation Profile BV in collaboration with our partner VarmX BV and scientists at Maastricht University and Leiden University, has been accepted for publication in Research and Practice in Thrombosis and Haemostasis [ link ]. The study, entitled “ Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001 ”, addresses an important clinical challenge, namely the need for

Coagulation Profile BV extends its warm congratulations to Sanofi on the recent FDA approval of Qfitlia (fitusiran), an innovative...

Coagulation Profile to Present Abstract on Intrinsic Thrombin Generation at GTH Congress in Lausanne on February 18-21th 2025 In a...

Coagulation Profile to Present Abstract on Intrinsic Thrombin Generation at EAHAD in Milan on February 5th 2025 Congress In a...

Coagulation Profile B.V. offers thrombin generation assays by means of the Calibrated Automated Thrombogram for pre-clinical and clinical...